Adaptive Biotechnologies
ADPT
ADPT
210 hedge funds and large institutions have $921M invested in Adaptive Biotechnologies in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 68 increasing their positions, 80 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 80
22% less capital invested
Capital invested by funds: $1.18B → $921M (-$258M)
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
Holders
210
Holding in Top 10
2
Calls
$2.39M
Puts
$568K
Top Buyers
| 1 | +$8.38M | |
| 2 | +$8.04M | |
| 3 | +$7.12M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$7.11M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$5.75M |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$2.52M | |
| 3 | -$2.1M | |
| 4 |
BlackRock
New York
|
-$1.92M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.72M |